Network origin in Mauro Magnani first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.
16
| Subsidiary | Medical Specialties | 16 |
University of Urbino
3
| College/University | Other Consumer Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mauro Magnani via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Corporate Officer/Principal Chief Executive Officer Director/Board Member | |
| QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
Innogest SGR SpA
 Innogest SGR SpA Investment ManagersFinance Innogest SGR SpA (Innogest) is a private equity firm founded in 2005 by Claudio Giuliano and Marco Pinciroli. The firm is headquartered in Milan, Italy. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Atricath SpA
 Atricath SpA Miscellaneous Commercial ServicesCommercial Services Atricath SpA is a holding company, which engages in the research and development of technology for the treatment of atrial fibrillation. The company was founded by Enrico Perfler and is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ANIMA HOLDING SPA | Investment Managers | Director/Board Member Director/Board Member | |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Investment Managers | Founder Founder | |
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
Congenia Srl
 Congenia Srl Miscellaneous Commercial ServicesCommercial Services Congenia SRL operates as pharmaceutical company, is engaged in the development of novel therapeutics for diseases associated with mitochondrial stress-induced dysfunction. The company develops small molecule drugs that target the mitochondrial permeability transition pore, a protein channel with various macromolecular components that along with mitochondrial protein p66, appears to be associated with oxidative stress-induced cell death. The company was founded in 2004 by Saverio Minucci, Pier Giuseppe Pelicci, Marco Giorgio and Paolo Bernardi and is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
| University of Bocconi | College/University | Undergraduate Degree Doctorate Degree | |
Betaglue Technologies SpA
 Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Newronika SRL
 Newronika SRL Medical SpecialtiesHealth Technology Newronika SRL manufactures medical and electro-medical equipment and appliances. It offers new adaptive deep brain stimulation systems for movement disorders (DBS); methods and devices for transcranial direct current stimulation (tDCS) represent the non-invasive neuromodulation activity. The company was founded by Priori Alberto and Lorenzo Rossi and is headquartered in Milan, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
| Sapienza University of Rome | College/University | Doctorate Degree Corporate Officer/Principal | |
| Pharmacia & Upjohn SpA | Corporate Officer/Principal Corporate Officer/Principal | ||
Assobiotec
 Assobiotec Miscellaneous Commercial ServicesCommercial Services Assobiotec is an organization that represents approximately 130 companies and technological and scientific parks in the biotech sector. Assobiotec is based in Milan, Italy. The Italian company focuses on various areas such as health, agriculture, environment, and industrial processes. The private company was founded in 1986, and the CEO is Leonardo Vingiani. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chairman Chief Executive Officer | |
| The European Association for Bioindustries | Corporate Officer/Principal Chairman | ||
| University of Milan | College/University | Undergraduate Degree Director/Board Member | |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
| Cogentech Scarl | Director/Board Member | ||
| COMPAGNIE INDUSTRIALI RIUNITE S.P.A. | Motor Vehicles | Director/Board Member | |
| University of Milano-Bicocca | College/University | Director/Board Member | |
| CIR S.P.A. - COMPAGNIE INDUSTRIALI RIUNITE | Auto Parts: OEM | Director/Board Member | |
Bormioli Pharma SpA
 Bormioli Pharma SpA Miscellaneous ManufacturingProducer Manufacturing Bormioli Pharma SpA designs and manufactures pharmaceutical packaging solutions. It offers packaging for dual-chamber system, oral, parenteral, ophthalmic and nasal drugs. The company was founded in 2017 and is headquartered in Parma, Italy. | Miscellaneous Manufacturing | Director/Board Member | |
| University of Parma | College/University | Undergraduate Degree | |
| Friends of Telethon Foundation Italy, Inc. | Director/Board Member | ||
NanoCellect Biomedical, Inc.
 NanoCellect Biomedical, Inc. BiotechnologyHealth Technology NanoCellect Biomedical, Inc. develops flow cytometry and cell sorting technology solutions for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine. Its products include wolf cell sorter and N1 single cell dispenser. The company was founded by Nate Heintzman and Yuhwa Lo in 2009 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| RENOVACOR, INC. | Biotechnology | Director/Board Member | |
Menarini-Silicon Biosystems SpA
 Menarini-Silicon Biosystems SpA SemiconductorsElectronic Technology Menarini-Silicon Biosystems SpA develops and distributes lab-on-a-chip technologies for miniaturized cell-biology testing. The company was founded by Nicol? Manaresi and Gianni Medoro and is headquartered in Castel Maggiore, Italy. | Semiconductors | Director/Board Member | |
Dompe Farmaceutici SpA
 Dompe Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Dompé in 1940 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer | |
Fondazione Telethon
 Fondazione Telethon Investment Trusts/Mutual FundsMiscellaneous Part of Founders Combined Charity Income Common Investment Fund, Fondazione Telethon finances research to find a cure for all rare genetic diseases. The company is based in Rome, Italy. The Italian company's method involves selecting the best research projects based on criteria such as excellence, rigor, and merit to offer answers to patients. The company offers many ways to support research and collaborate with Telethon to bind your company to social values. Discover all the goals and future projects of their foundation. | Investment Trusts/Mutual Funds | Director/Board Member | |
Pfizer Srl (Italy)
 Pfizer Srl (Italy) Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Srl (Italy) is an Italian pharmaceutical company that manufactures pharmaceutical products. The company is based in Latina, Italy. The company was founded by Charles Erhart, Charles Pfizer. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DIASORIN S.P.A. | Medical Specialties | Director/Board Member | |
| UNIPOLSAI ASSICURAZIONI S.P.A. | Multi-Line Insurance | Director/Board Member | |
| BIESSE S.P.A. | Industrial Machinery | Director/Board Member | |
| Alma Mater Studiorum - Università di Bologna | College/University | Graduate Degree | |
| UNIPOL GRUPPO S.P.A. | Multi-Line Insurance | Director/Board Member | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| International Rare Diseases Research Consortium | Corporate Officer/Principal | ||
| DYNE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Numab Therapeutics AG
 Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
VectorY BV
 VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Chairman | |
| University of Uppsala | College/University | Undergraduate Degree |
Statistics
International
| Italy | 35 |
| United States | 10 |
| Belgium | 2 |
| United Kingdom | 2 |
| France | 2 |
Sectoral
| Health Technology | 18 |
| Finance | 8 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Producer Manufacturing | 4 |
Operational
| Director/Board Member | 94 |
| Corporate Officer/Principal | 44 |
| Independent Dir/Board Member | 20 |
| Chairman | 15 |
| Private Equity Investor | 10 |
Most connected contacts
| Insiders | |
|---|---|
| Graziano Seghezzi | 26 |
| Claudius Rumazza | 20 |
| Paolo Fundarò | 17 |
| Francesca Pasinelli | 15 |
| Claudio Giuliano | 15 |
| Carlo Incerti | 14 |
| Franco Rutili | 13 |
| Luca Benatti | 12 |
| Lorenzo M. Tallarigo | 11 |
| Federica Draghi | 9 |
| Rita Laura D’Ecclesia | 8 |
| Elisabetta Righini | 7 |
| Alyssa Wyant | 6 |
| Giovanni Mambrini | 5 |
| Carrie D'Andrea | 4 |
- Stock Market
- Insiders
- Mauro Magnani
- Company connections
